— Know what they know.
Not Investment Advice

UPB NASDAQ

Upstream Bio, Inc.
1W: -3.8% 1M: -12.2% 3M: +4.7% YTD: -67.6% 1Y: +11.6%
$8.37
-0.09 (-1.06%)
 
Weekly Expected Move ±7.0%
$8 $8 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 31 · $455.5M mcap · 20M float · 3.99% daily turnover · Short 30% of daily vol

Balance Sheet Trends

Total Assets
$354M -26.6% ▼
3Y CAGR: +167.5%
Total Liabilities
$14M +18.0% ▲
3Y CAGR: -51.7%
Shareholders Equity
$340M -27.7% ▼
Cash & Investments
$342M -27.4% ▼
3Y CAGR: +171.6%
Total Debt
$1M -30.8% ▼
3Y CAGR: +138.1%
Net Debt
-$100M +69.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$17M$26M$326M$102M
Short-Term Investments$0$84M$145M$240M
Cash & ST Investments$17M$110M$470M$342M
Net Receivables$412K$236K$1M$668K
Inventory$0$0$0$0
Other Current Assets$233K$370K$494K$10M
Total Current Assets$18M$117M$479M$352M
Property, Plant & Equip.$164K$202K$2M$2M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$7K$0$194K$194K
Total Non-Current Assets$171K$202K$3M$2M
Total Assets$18M$117M$482M$354M
— Liabilities —
Accounts Payable$712K$2M$4M$3M
Short-Term Debt$0$0$0$720K
Deferred Revenue$0$0$0$0
Other Current Liabilities$893K$2M$3M$10M
Total Current Liabilities$5M$7M$11M$13M
Long-Term Debt$0$0$0$549K
Other Non-Current Liab.$120M$234M$0$0
Total Non-Current Liabilities$120M$234M$1M$549K
Total Liabilities$125M$240M$12M$14M
— Equity —
Common Stock$3K$3K$53K$54K
Retained Earnings-$107M-$128M-$191M-$334M
Accumulated OCI$0$21K-$25K$530K
Total Stockholders Equity-$106M-$123M$470M$340M
Total Liabilities & Equity$18M$117M$482M$354M
— Key Metrics —
Total Debt$94K$45K$2M$1M
Net Debt-$17M-$26M-$324M-$100M
Total Investments$0$84M$145M$240M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms